Back to REGN
GRANDFIELD & DODD, LLC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$28.1M
Q3 2026
Peak value
$28.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $28.2M |
| Q1 2026 | $28.1M |
| Q2 2026 | $22.8M |
| Q3 2026 | $28.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $28.1M | 37.1K | — | — |
| Q2 2026 | $22.8M | 36.6K | — | — |
| Q1 2026 | $28.1M | 36.4K | — | — |
| Q4 2025 | $28.2M | 36.6K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B